340B in the Crosshairs: Pharma-Backed Ads Target Lawmakers Over Drug Discount Support
A look at how pharmaceutical-backed advertising is shaping the debate around lawmakers who support the 340B program.
Read articlePractical perspectives on 340B, compliance, and pharmacy operations. No jargon. No vague promises. Just ideas teams can use.
A look at how pharmaceutical-backed advertising is shaping the debate around lawmakers who support the 340B program.
Read articleNebraska's approach highlights the growing state-level effort to protect access to 340B contract pharmacies.
Read articleColorado's proposed 340B expansion shows how access, oversight, and public accountability intersect in state policy.
Read articleResponsible 340B management balances financial sustainability with transparency, compliance, and patient benefit.
Read articleMichigan's legislative action adds momentum to state efforts protecting contract-pharmacy participation in 340B.
Read articleDrugstore closures can turn routine medication access into a major barrier for rural and underserved communities.
Read articlePharmacy technicians are taking on broader operational and patient-support responsibilities across modern pharmacy care.
Read articleSpecialty and retail pharmacies serve different medication, care, and operational needs—even as their services increasingly overlap.
Read articleManufacturer challenges to rejected rebate models could reshape cash flow, oversight, and access across the 340B program.
Read articleGeography can shape whether communities receive the access and support that 340B savings are intended to enable.
Read articleShared, tamper-resistant records could improve traceability across complex 340B drug and claims workflows.
Read articleA court challenge to West Virginia's contract-pharmacy law highlights the unresolved boundary between state and federal 340B authority.
Read articleStay curious
More OptimSync perspectives are on the way.